For comprehensive guidance on testing instructions and interpreting OraQuick In-Home HIV test results, refer to the directions provided with your in-home kit. Post-exposure detection of HIV may take up to three months, known as the window period, in which antibodies to the virus are developed. Testing during the window period may produce a negative result. With a positive result and if results are inconclusive seek additional testing in a medical setting.
As noted in the package insert, clinical studies have shown that the OraQuick In-Home HIV Test has an expected performance of approximately 92% for test sensitivity (i.e., the percentage of results that will be positive when HIV is present). This means that one false negative result would be expected out of every 12 test results in HIV infected individuals. The clinical studies also showed that the OraQuick In-Home HIV Test has an expected performance of 99.98% for test specificity (i.e., the percentage of results that will be negative when HIV is not present). This means that one false positive result would be expected out of every 5,000 test results in uninfected individuals.
It is extremely important for those who self-test using the OraQuick In-Home HIV Test to carefully read and follow all labeled directions. Even when used according to the labeled directions, there will be some false negative results and a small number of false positive results. The OraQuick test package contains step-by-step instructions, and there is also an OraQuick Consumer Support Center to assist users in the testing process.
A positive test result on the OraQuick In-Home HIV Test indicates that you may be infected with HIV. Additional testing in a medical setting will either confirm a positive test result or inform you that the initial result was a false positive result.
The manufacturers of unapproved test systems have not submitted data to FDA in order for FDA to review and determine whether their test systems can reliably detect HIV infection. Therefore, FDA cannot give the public any assurance that the results obtained using an unapproved test system are accurate.
The CDC recommends that everyone between the ages of 13 and 64 years old be screened for HIV at least once as part of their routine health care. More frequent testing is recommended for people who have a higher risk of infection because of behaviors such as having sex without condoms, having sex with multiple partners, or injecting drugs using shared needles.
The OraQuick In-Home HIV Test is the only HIV test approved by the FDA that people can use to test themselves at home or in a private location. OraQuick was approved in 2012 for sale in stores and online to anyone age 17 and older.
The kit contains a test stick you use to swab your upper and lower gums to collect an oral fluid sample from your mouth. The stick is then placed in a tube with a testing solution. After 20 to 40 minutes, one line will appear if the test is negative. Two lines indicate that HIV antibodies were detected and that you may be HIV positive.
Not necessarily. More testing done through a lab is needed to confirm your HIV status. Look at this as a first step in HIV testing. Because no test is perfect, there will be some false positive results. Clinical studies for self-testing have shown that the OraQuick test will produce one false positive result out of about every 5,000 tests in uninfected individuals.
If you get a positive result, it's very important that you follow up on the result with your health care professional for further testing and for treatment if the infection is confirmed. You can also call the OraQuick Consumer Support Center, which has counselors available 24 hours a day to answer questions and provide local referrals for follow-up testing and care.
For questions about OraQuick HIV Self-Test, or to report any problems or adverse effects, please contact our country representative at 0845 475 6725 and email@example.com.
For comprehensive guidance on testing instructions and interpreting OraQuick HIV Self-Test test results, refer to the directions provided with your in-home kit. Post-exposure detection of HIV may take up to three months, known as the window period, in which antibodies to the virus are developed. Testing during the window period may produce a negative result. With a positive result and if results are inconclusive seek additional testing in a medical setting.
The safe and easy OraQuick rapid HIV test kit allows a person to self-swab their mouth to get a result in 20 minutes. Beginning June 27, residents can get information and order a test for mailing to their DC address at GetCheckedDC.org.
This year marks the 25th anniversary of National HIV Testing Day. DC was one of the first jurisdictions in the country to recommend everyone ages 13 to 84 get tested at least once per year. In 2016, Mayor Bowser released the 90/90/90/50 Plan to End the HIV Epidemic in the District of Columbia. The plan set goals of 90% of people with HIV to know their status, 90% of people with HIV to be on treatment, 90% of people on HIV treatment to be virally suppressed and a 50% reduction in new HIV diagnoses.
The District has made progress on the first goal with more than 87% of District residents with HIV knowing their status. The home-based testing program provides new ways for people to know their status conveniently.
No matter the test result, DC Health and community partners are available to help. For people who test negative, DC Health offers options for them to stay HIV negative, including Pre-Exposure Prophylaxis or PrEP. PrEP is the safe, daily pill that prevents HIV.
For anyone who test positive, the good news is people with HIV can have long, happy and fulfilling lives. DC has high-quality medical care and other services for support. DC Health recommends scheduling an appointment with a medical provider or calling the DC Health and Wellness Center at (202) 741-7692. The Health and Wellness Center can start people on HIV medication the same day as the appointment.
OraQuick In-Home HIV Test. You can buy this test online or at a pharmacy. This quick-result test checks for HIV antibodies in a sample of saliva. You swab your upper and lower gums with a test stick. You then insert the sample into a vial filled with a fluid and wait 20-40 minutes and read the result.
The Home Access HIV-1 Test System is extremely reliable. Studies show that it will detect HIV antibodies -- indicating that your blood has virus that causes AIDS -- more than 99.9% of the time. When your sample gets a positive result, the lab will confirm it with another test before you can call for your result.
But experts recommend that if you test positive on OraQuick, you should view the results as preliminary. You should confirm it with a second test from your doctor or a medical clinic so that you can get the care you need.
The Virginia Department of Health FREE HIV Self-Testing Program makes HIV testing even easier to access! Eligible residents of Virginia and Maryland can receive an HIV self-test to take in the privacy of their home or where is convenient.
If the follow-up test is also positive, you will start daily antiretroviral medication to lower your viral load. While not a cure, it is possible to reduce the viral load to levels undetectable by lab tests.
Both positive and negative HIV tests may need to be repeated 1 to 3 months after potential exposure to HIV infection (this is known as the window period), but you should not wait this long to seek help:
Several countries have recently recommended the expansion of anti-human immunodeficiency virus (HIV) antibody testing, including self-testing with rapid tests using oral fluid (OF). Several tests have been proposed for at-home use, but their diagnostic accuracy has not been fully evaluated.
Prospective multi-center study in France. HIV-infected adults and HIV-uninfected controls were systematically screened with 5 at-home HIV tests using either OF or finger-stick blood (FSB) specimens. Four OF tests (OraQuick Advance Rapid HIV-1/2, Chembio DPP HIV 1/2 Assay, test A, and test B) and one FSB test (Chembio Sure Check HIV1/2 Assay) were performed by trained health workers and compared with laboratory tests.
In total, 179 HIV-infected patients (M/F sex ratio: 1.3) and 60 controls were included. Among the HIV-infected patients, 67.6% had an undetectable HIV viral load in their plasma due to antiretroviral therapy. Overall, the sensitivities of the OF tests were 87.2%, 88.3%, 58.9%, and 28% (for OraQuick, DPP, test A, and test B, respectively) compared with 100% for the FSB test Sure Check (p
In France, rapid HIV tests using blood samples are currently implemented at health care centers for professional use and have been available to trained volunteers working in community AIDS associations since 2010. In England, rapid tests are well accepted by the population , as these tests are easy to use and can be performed by trained staff, with results obtained within a few minutes . However, these tests are currently only available at certain medical facilities, and the French AIDS National Council (CNS) recently recommended that their use should be expanded . Some men having sex with men (MSM) admit that they administer self-tests that are sold illegally on websites, indicating that autonomous self-testing may reduce barriers to testing in this vulnerable population . The USA has recently authorized the marketing and commercialization of the over-the-counter OraQuick OF in-home test, which can be used without any prior training or assistance from health professionals. In France, the National Ethic Committee and National AIDS Council (CNS) recently approved the implementation of self-testing for HIV diagnosis, provided that the test accuracy is deemed acceptable through public health policy ,.
The study was conducted from January to July 2013 in 3 French health centers: La Rochelle, Poitiers